A University of Queensland project aims to make the teenage years safer for Australian children diagnosed with life-threatening food allergies.
Alirocumab reduces dangerous coronary plaque and stabilizes high-risk lesions
Intensive LDL-C lowering with alirocumab significantly reduces high-risk coronary plaque burden, transforming unstable plaques into more stable phenotypes. This lesion-level analysis underscores the enhanced efficacy